Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical Practice.

Christian Zanchin,Yasushi Ueki,Thomas Zanchin,Jonas Häner,Tatsuhiko Otsuka,Stefan Stortecky,Konstantinos C Koskinas,George C M Siontis,Fabien Praz,Aris Moschovitis,Lukas Hunziker,Marco Valgimigli,Thomas Pilgrim,Dik Heg,Stephan Windecker,Lorenz Räber

JACC: Cardiovascular Interventions（2019）

引用 26|浏览49

暂无评分

摘要

In this consecutively enrolled percutaneous coronary intervention population reflecting routine clinical practice, no difference in the device-oriented composite endpoint between BP-EES and DP-EES was observed throughout 12 months. There was a higher rate of acute stent thrombosis with the BP-EES, a difference that disappeared at 1 year. (CARDIOBASE Bern PCI Registry; NCT02241291).

查看译文

关键词

coronary artery disease,drug-eluting stent,restenosis,stent thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要